Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer - Cell Death Discovery Cell Death Discovery - Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer

Happy to share two big milestones—PhD completed & our main study now published in Cell Death Discovery www.nature.com/articles/s41...
Currently seeking postdoc roles!

#Postdoc #Epigenetics #PhDComplete #PostdocCancer #PostdocEpigenetics #Cancer #CisplatinResistance